Central Auditory Disorders

When the patient cannot decode speech-in-noise but every brainstem measure is normal, the lesion is above the inferior colliculus and the workup is behavioural.

What ABR can and cannot tell you

ABR samples the auditory pathway up to the inferior colliculus and stops. Lesions above — thalamocortical, primary auditory cortex, association cortex — leave the ABR untouched1. A normal ABR in a patient with disproportionate listening-in-noise difficulty is itself a finding: it redirects the workup away from the periphery and brainstem and toward central processing.Foundation

CAPD — central auditory processing disorder

CAPD describes a heterogeneous group of difficulties with the efferent and cortical handling of auditory input despite normal peripheral hearing2. Diagnosis rests on a behavioural test battery: speech-in-noise with controlled SNR, dichotic digits, dichotic sentences, frequency or duration patterns, and gap detection. ABR is part of the workup to confirm that the periphery and brainstem are not the bottleneck.

The middle-latency response (MLR) Trainee

The MLR is the next evoked-potential layer above the ABR, between roughly 10 and 80 ms3. Its Na–Pa complex reflects thalamocortical and primary auditory-cortex generators. A normal ABR with an abnormal MLR localises a lesion above the inferior colliculus — usually thalamic or cortical. MLR is technically more demanding than ABR (sensitive to sleep state and electrode position) but adds anatomical reach when needed.

P300 and cortical ERPs

The P300 is a cognitive event-related potential reflecting attention and stimulus evaluation in associative cortex around 300 ms. It is used in research and select clinical settings; not a routine workup component.

When central testing matters

Children failing in noisy classrooms despite normal audiograms, adults reporting disproportionate difficulty after acoustic neuroma surgery or radiation, post-stroke or post-TBI patients with hearing complaints exceeding their audiogram — these are the populations in whom the ABR-MLR-behavioural battery yields the most. Clinician